Finland· FI-REL-REL10403
Neotigason
A acitretin product containing acitretin, registered in Finland by Paranova Oy. The same ATC class is registered in 17 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Acitretin is registered in 17 of 19 countries.
Countries holding a registration under ATC D05BB02 (acitretin), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 10 of them publish a price we can compare per daily dose
Acitretin · ATC D05BB02
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of acitretin costs, country by country.
Normalised to the WHO defined daily dose (35 mg), the median price runs from $2.08 in Italy to $4.37 in Switzerland — a ×2.1 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Acitretin · price per daily dose (35 mg)
USD · FX 28 Sept 2026
- CH Switzerland$4.37
- IT Italy$2.08
The record
At a glance
Fimea (Finland)- Active substance
- Acitretin
- Manufacturer
- Paranova Oy
- Country
- Finland (FI)
- ATC code
- D05BB02
- ATC class
- Acitretin
- Defined daily dose
- 35 mg, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
147 interactions on record for acitretin.
Graded by severity as the source publishes them — 39 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Acitretin · interactions on record
147 records
- 39 severe
- 30 moderate
- 75 info
Most severe, free to view
- EthanolB05XX04severe
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- IsotretinoinD10AD04severe
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Acitretin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAcitretinAlembic Pharmaceuticals Inc.
- United KingdomAcitretin 25mg capsulesA A H Pharmaceuticals Ltd
- SwitzerlandAcicutan
- BelgiumNeotigason 25 mgPI Pharma
- CanadaMINT-ACITRETINMINT PHARMACEUTICALS INC
- NetherlandsAcitretine CF 25 mg, capsulesCentrafarm B.V.
- NorwayAcitretin OrifarmOrifarm Generics A/S
- SpainACITRETINA IFC 25 mg CAPSULAS DURAS EFGIndustrial Farmaceutica Cantabria S.A.
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Keracutan
- Belgium · Neotigason
- Czechia · Neotigason
- Germany · Acicutan, Neotigason
- Denmark · Acitretin Orifarm, Neotigason
- Estonia · Neotigason
- Spain · Acitretina Ifc, Neotigason
- France · Soriatane
- United Kingdom (Northern Ireland) · Acitretin Genus Pharmaceuticals, Acitretin Morningside Healthcare
- Croatia · Neotigason
- Hungary · Neotigason
- Ireland · Neotigason
- Iceland · Neotigason
- Italy · Neotigason, Zorias
- Lithuania · Neotigason
- Luxembourg · Neotigason
- Latvia · Neotigason
- Netherlands · Acitretin Aurobindo, Acitretine Cf
- Norway · Acitretin Orifarm, Neotigason
- Poland · Acitren, Neotigason
- Portugal · Neotigason
- Sweden · Acitretin Orifarm, Neotigason
- Slovenia · Neotigason
- Slovakia · Neotigason
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ff2a047d-0a17-46a3-84f5-f9ee5d8c1fc1 GET /v1/drugs/ff2a047d-0a17-46a3-84f5-f9ee5d8c1fc1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "35",
"form": "kapseli, kova",
"route": null,
"ddd_unit": "mg",
"strength": "25 mg",
"atc_label": "asitretiini",
"ma_number": "13601",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL10403",
"authorised_at": "2000-01-31"
}See everything about acitretin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.